BUY Niva Bupa Health Insurance Company Limited — Nomura India Research
byNomura India ResearchHorizon: NA (inferred 1 year)6 Nov 2026via Financial Express Market
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
Niva Bupa reported strong Q2 FY27 results with a 35% growth in Gross Written Premium to 2,484 crores and a 124% increase in Profit After Tax to 136 crores.
BSE · Company Update·4 Nov · 2d ago
Niva Bupa reported strong Q2 FY27 results with a 35% growth in Gross Written Premium to 2,484 crores and a 124% increase in Profit After Tax to 136 crores.
NSE · Press Release·4 Nov · 2d ago
Niva Bupa Health Insurance reported unaudited financial results for the quarter and half-year ended September 30, 2026, showing a profit of Rs 13,564 lakhs for the quarter.
BSE · Board Meeting·4 Nov · 3d ago
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·30 Jul · 3mo ago
Niva Bupa Health Insurance Company Limited reported unaudited financial results for the quarter and half year ended September 30, 2026.
NSE · Outcome of Board Meeting·4 Nov · 3d ago
Niva Bupa issues call option notice for ₹150 crore NCD redemption
NewsGoogle News·15 Oct · 3w ago
Niva Bupa Health Insurance NCD Call Option November 2026
NewsGoogle News·15 Oct · 3w ago
Niva Bupa Health Insurance has approved the exercise of a call option for its non-convertible debentures worth Rs 150 crore, with redemption and interest payment scheduled for November 13, 2026.
BSE · Board Meeting·9 Oct · 4w ago
1 advisor has an active short-term SELL call on this stock
Advisor consensus · adjacent horizon·29 Sept · 1mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Niva Bupa Health Insurance Company
- BUY — Sumeet Bagadia, Choice Broking25 Oct 2026 · ~3 months · target ₹78 · Target hit
- SELL — Nagaraj Shetty, HDFC Securities29 Sept 2026 · ~3 months · target ₹70 · Active
- BUY — IDBI Capital21 Sept 2026 · ~2 weeks · target ₹85.3 · SL hit
- BUY — Osho Krishan, Angel One30 Jul 2026 · ~2 weeks · target ₹92 · Expired
- BUY — Motilal Oswal30 Jul 2026 · ~1 year · target ₹103 · Active
More from Nomura India Research
- BUY Bharat Electronics6 Nov 2026 · ~1 year · target ₹520 · Active
- BUY Aadhar Housing Finance6 Nov 2026 · ~1 year · target ₹565 · Active
- BUY Exide Industries6 Nov 2026 · ~1 year · target ₹501 · Active
- BUY UNO Minda6 Nov 2026 · ~1 year · target ₹1,629 · Active
- BUY Clean Max Enviro Energy Solutions6 Nov 2026 · ~1 year · target ₹1,565 · Active

